Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Associate Professor Robert Brink

 

Senior Research Fellow; Leader, Immunology Program, and Group Leader B Cell Biology, Garvan Institute of Medical Research

Email: r.brink 'at' garvan.org.au
Research Group: B Cell Biology

 
 
Robert first became interested in immunology as an undergraduate upon learning of the incredible processes by which B cells rearrange and mutate their immunoglobulin genes in order to generate antibody diversity. After completing his PhD on B cell activation and self-tolerance, he was awarded a CJ Martin Overseas Biomedical Fellowship in 1994.
 
 
 

Robert undertook his postdoctoral studies at the Whitehead Institute in Boston, where he furthered his molecular skills and worked on TNF receptors their signalling molecules. Upon returning to Australia, he generated gene-targeted mice designed with which to visualise B cell responses and analyse gene function in vivo. Robert joined Garvan as a Senior Research Fellow in 2006 and continues to use these in vivo models to uncover how B cells function during protective immune responses, autoimmune disease and lymphomagenesis.

Education

1992 PhD (Medicine) Centenary Institute of Cancer Medicine and Cell Biology University of Sydney
1986 BSc (Hons I) Department of Biochemistry University of Sydney

Awards and Honours

2006 NHMRC Senior Research Fellowship
1994 NHMRC CJ Martin Research Fellowship
1991 University of Sydney Medical Foundation Fellowship
1988 Australian Postgraduate Research Award

Selected Publications

Chan TD, Gatto D, Wood K, Camidge T, Basten A and Brink R (2009) Antigen affinity controls rapid T-dependent antibody production by driving the expansion rather than the differentiation or extrafollicular migration of early plasmablasts. J. Immunol. 183: 3139-3149.

Gatto D, Paus D, Basten A, Mackay C and Brink R (2009) Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses. Immunity. 31: 259-269.

Gardam S, Sierro F, Basten A, Mackay F and Brink R (2008) TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity. 28: 391-401.

Brink R, Phan TG, Paus, D and Chan TD (2008) Visualising the effects of antigen affinity on T-dependent B cell differentiation. Immunol. Cell Biol. 86: 31-39.

Vince JE, Wong WW, Khan N, Feltham R, Chau, D, Ahmed AU, Chan D, Benetatos CA, Chunduru SK, Condon SM, McKinlay M, Brink R, Leverkus M, Tergaonkar V, Schneider P, Callus BA, Koentgen F, Vaux DL and Silke J. (2007) IAP antagonists target cIAP1 to induce TNF-dependent apoptosis. Cell. 131: 682-693.

Brink R. (2007) Germinal-center B cells in the zone. Immunity. 26: 552-554.

Phan TG, Paus D, Chan TD, Turner ML, Nutt SL, Basten A and Brink R. (2006). High affinity germinal center B cells are actively selected into the plasma cell compartment. J. Exp. Med. 203: 2419-2424.

Paus D, Phan TG, Chan TD, Gardam, S, Basten A and Brink R. (2006) Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J. Exp. Med. 203: 1081-1091.

Brink R. (2006) Regulation of B cell self-tolerance by BAFF. Sem. Immunol. 18: 276-283.

Grech AP, Gardam S, Chan T, Quinn R, Gonzales R, Basten A and Brink R. (2005) Tumor necrosis factor receptor 2 (TNFR2) signaling is negatively regulated by a novel, carboxyl-terminal TNFR associated factor 2 (TRAF2) binding site. J. Biol. Chem. 280: 31572-31581.

Phan TG, Gardam S, Basten A and Brink R. (2005) Altered migration, recruitment and somatic hypermutation in the early response of marginal zone B cells to T cell-dependent antigen. J. Immunol. 174: 4567-4578.

Grech AP, Amesbury M, Chan T, Gardam S, Basten A and Brink R. (2004) TRAF2 differentially regulates the canonical and non-canonical pathways of NF-B activation in mature B cells. Immunity. 21: 629-642.

Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F and Brink R. (2004) Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 20: 785-798.

Phan TG, Amesbury M, Gardam S, Crosbie J, Hasbold J, Hodgkin PD, Basten A and Brink R. (2003) B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J. Exp. Med. 197: 845-860.

Grech A, Quinn R, Srinivasan D, Badoux X and Brink R. (2000) Complete structural characterisation of the mammalian and Drosophila TRAF genes: implications for TRAF evolution and the role of RING finger splice variants. Mol. Immunol. 37: 721-734.

 

Search for all publications by R Brink

 
 
 

Areas of Interest

Lymphoma, autoantibody-mediated autoimmune diseases, lupus, myasthenia gravis, hemolytic anemia
 

News

 

How the immune system positions its gatekeepers

MEDIA RELEASE: 18 Mar 2013
For an immune response to get underway, an invading microbe must first be halted in the spleen, and then digested by immune cells known as ‘dendritic cells’, which guard specific portals. Garvan scientists have now shown how these gatekeepers position themselves to undertake their task. The findings are now published online today in the prestigious journal Nature Immunology.
 
 

How infection can trigger autoimmune disease

MEDIA RELEASE: 09 Nov 2012
Garvan scientists have confirmed a ‘weak link’ in the immune system – identifying the exact conditions under which an infection can trigger an autoantibody response, a process not clearly understood until now.
 
 

Garvan performs well in NHMRC grants round

24 Oct 2012
Garvan received $19.6 million in the latest round of National Health and Medical Research Council grants, announced last Friday by the federal Minister for Health, Tanya Plibersek, at the University of Sydney. The Institute performed at least 50% above the national average, receiving 12.5% of funding awarded to NSW as a whole, and 3% of the national total. The minister announced a total of $652 million for 1141 grants in medical research across Australia.
 
 

Personal tools